Pliant Therapeutics (PLRX) Return on Sales (2020 - 2024)
Pliant Therapeutics (PLRX) posted quarterly Return on Sales of 8.58% for Q1 2024, down 827.0% year-over-year from 1.18% in Q2 2023, and down 574.99% quarter-over-quarter from 1.27% in Q4 2023.
Pliant Therapeutics (PLRX) Return on Sales (2020 - 2024) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Return on Sales for 5 consecutive years, with 8.58% the latest figure, recorded in Q1 2024.
- In Q1 2024, Return on Sales fell 827.0% year-over-year to 8.58%; the TTM figure through Mar 2024 stood at 8.58% (down 844.0% YoY), while the FY2023 annual figure was 2.13%, down 188.0% from the prior year.
- Return on Sales retreated to 8.58% in Q1 2024 per PLRX's latest filing, from 1.27% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q1 2020 and bottomed at 8.58% in Q1 2024.
- Historically, Return on Sales has averaged 0.82% across 5 years, with a median of 0.17% in 2021.
- Annual changes were most pronounced in 2022 — Return on Sales grew 7 bps — and 2024, when it slumped 827 bps.
- Pliant Therapeutics' Return on Sales stood at 0.04% in 2020, then slumped by 171 bps to 0.12% in 2021, then plunged by 55 bps to 0.18% in 2022, then tumbled by 598 bps to 1.27% in 2023, then tumbled by 575 bps to 8.58% in 2024.
- Business Quant data shows PLRX's Return on Sales at 8.58% in Q1 2024, 1.27% in Q4 2023, and 0.49% in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -8.58% |
| Dec 31, 2023 | -1.27% |
| Sep 30, 2023 | -0.49% |
| Jun 30, 2023 | -1.96% |
| Mar 31, 2023 | -0.31% |
| Dec 31, 2022 | -0.18% |
| Sep 30, 2022 | -0.23% |
| Jun 30, 2022 | -0.06% |
| Mar 31, 2022 | -0.24% |
| Dec 31, 2021 | -0.12% |
| Sep 30, 2021 | -0.17% |
| Jun 30, 2021 | -0.13% |
| Mar 31, 2021 | -0.11% |
| Dec 31, 2020 | -0.04% |
| Sep 30, 2020 | -0.03% |
| Jun 30, 2020 | -0.05% |
| Mar 31, 2020 | 0.00% |